Kraig Biocraft Laboratories (KBLB) Notes Payables (2016 - 2025)

Kraig Biocraft Laboratories (KBLB) has 10 years of Notes Payables data on file, last reported at $1.5 million in Q4 2025.

• For the quarter ending Q4 2025, Notes Payables fell 7.73% year-over-year to $1.5 million; the trailing twelve-month figure through Dec 2025 stood at $1.5 million (down 7.73% YoY), and the FY2025 full-year result was $1.5 million, down 7.73% from the prior year.
• Notes Payables retreated to $1.5 million in Q4 2025, from $1.6 million in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $5.5 million in Q3 2022 to a low of $285997.0 in Q1 2021.
• A 5-year average of $1.8 million and a median of $1.6 million in 2022 frame the typical range for Notes Payables.
• Across the five-year window, Notes Payables jumped 465.39% in 2022 and plunged 70.75% in 2023, its largest moves.
• Tracing KBLB's Notes Payables over 5 years: stood at $503423.0 in 2021, then jumped by 221.2% to $1.6 million in 2022, then changed by 0.0% to $1.6 million in 2023, then changed by 0.0% to $1.6 million in 2024, then decreased by 7.73% to $1.5 million in 2025.
• Business Quant data shows KBLB's Notes Payables at $1.5 million in Q4 2025, $1.6 million in Q3 2025, and $1.6 million in Q2 2025.